Clinical trial
Association Between Zonulin and Lipopolysaccharide-binding Protein as Biomarkers of Intestinal Permeability and Hepatic Steatosis in Patients With Ulcerative Colitis
NCT07662902 is registered in ClinicalTrials.gov with University Hospital Dubrava as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Association Between Zonulin and Lipopolysaccharide-binding Protein as Biomarkers of Intestinal Permeability and Hepatic Steatosis in Patients With Ulcerative Colitis
- Lead sponsor
- University Hospital Dubrava
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- December 1, 2025
- Completion date
- May 31, 2027
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intestinal permeability, steatotic liver disease, ulcerative colitis (uc)